Samsung C&T (028260)

[Business Overview] Samsung C&T is the Samsung Group's holding/operating company combining four segments: Construction (one of Korea's largest E&C firms, building Samsung Electronics fabs and major overseas projects), Trading (Korean conglomerate-style trading house with global commodities and industrial materials), Fashion (Samsung-brand SPA, premium fashion), and Bioindustry/Resort (Everland theme park, golf, Samsung Bioepis stake). [Core Competitiveness] Samsung C&T's structural advantage is its position at the apex of the Samsung Group ownership chain — it holds significant stakes in Samsung Electronics, Samsung Biologics, Samsung Life, and Samsung SDS — making it both an operating company and a Samsung-group holding vehicle. The construction backlog is long-cycle and high-quality, anchored by Samsung Electronics' multi-year fab build-outs in Korea and Texas. [Earnings Analysis] 2024–2025 results were carried by construction (semiconductor fab projects) and resort (Everland post-pandemic recovery), with trading and fashion contributing more variable earnings. NAV-based valuations remain depressed versus the underlying Samsung-group stake portfolio. [Financial Health] Strong consolidated balance sheet supported by listed-company stakes worth tens of trillions of KRW. Construction working capital absorbs cash through fab project cycles. [Outlook] Samsung Electronics fab CapEx pipeline (especially Texas Taylor and the Pyeongtaek expansions), governance/restructuring developments, and Korea Value-up program inclusion are the principal swing factors.